Metastatic Prostate Cancer Clinical Trials

192 clinical trials for Metastatic Prostate Cancer across international registries, including 50 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer — RECRUITING · PHASE2
• A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer — RECRUITING · PHASE1
• A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer — RECRUITING · PHASE1
• First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer — RECRUITING · PHASE1
• Collection of Blood From Patients With Prostate Cancer — RECRUITING
• Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) — RECRUITING · PHASE2
• High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers — RECRUITING · PHASE2
• Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers — RECRUITING · PHASE4
• Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer — RECRUITING · PHASE1
• PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer — RECRUITING
• Study of ORIC-944 in Patients With Metastatic Prostate Cancer — RECRUITING · PHASE1
• Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer — RECRUITING
• Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer — RECRUITING · PHASE1
• Study of HLD-0915 in Patients With Metastatic Prostate Cancer — RECRUITING · PHASE1
• A Phase I/II Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6621, a T Cell-engaging Antibody That Targets STEAP2, CD3, and CD8 in Adult Participants With Metastatic Prostate Cancer (ACTIVATED-4-PC) — RECRUITING · PHASE2
• A Study of Tarlatamab for People With Prostate Cancer — RECRUITING · PHASE2
• First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer — RECRUITING · PHASE1
• Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression — RECRUITING · PHASE3
• 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer — RECRUITING · PHASE1
• Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer — RECRUITING · NA
• ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium — RECRUITING · PHASE1
• Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006) — RECRUITING · NA
• Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes — RECRUITING · PHASE3
• A Phase I/II, Modular, Open-Label, Multi-Centre Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD9750 as Monotherapy and in Combination with Other Anticancer Agents in Participants with Metastatic Prostate Cancer (ANDROMEDA) — RECRUITING · PHASE2
• Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer — RECRUITING · PHASE2
• Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) — RECRUITING
• Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration — RECRUITING
• Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial — RECRUITING · NA
• Study of AZD0754 in Participants With Metastatic Prostate Cancer — RECRUITING · PHASE1
• Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer — RECRUITING · PHASE2
• Pharmaceutical Management in Targeted Radioligand Therapy — RECRUITING
• Physician- and Patient-based Barriers to NGS Testing — RECRUITING · NA
• Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer — RECRUITING · PHASE2
• Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT — RECRUITING · PHASE1
• 68Ga-PSMA PET/CT for Ra223 Assessment — RECRUITING · NA
• Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) — RECRUITING
• Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer — RECRUITING · NA
• TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer — RECRUITING · NA
• Measuring Oncological Value of Exercise and Statin — RECRUITING · PHASE3
• PRostate Cancer Plasma Integrative Multi-modal Evaluation — RECRUITING
• European Registry of Next Generation Imaging in Advanced Prostate Cancer — RECRUITING
• [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer — RECRUITING · PHASE1
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab — RECRUITING · PHASE1
• Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC) — RECRUITING · PHASE2
• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer — RECRUITING · PHASE4
• The Impact of Radiotherapy on Oligometastatic Cancer — RECRUITING
• Combination of TURP and Standard Systemic Therapy for MPCa — RECRUITING · PHASE2
• Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients — RECRUITING · PHASE3
• Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC — RECRUITING · PHASE3
• Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC — RECRUITING · PHASE3

Refine this search